- Location
treatment of breast cancer
"-
IBM Research and IBN Discover Deliver Treatment More Efficiently to Fight Breast Cancer
Nov 5, 2013Scientists from IBM and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver ...
Tags: Cancer Drug, Medicine
-
510(K) Clearance for Prosigna Assay Is Obtained by Nanostring Technologies
Sep 12, 2013NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has obtained the US Food and Drug Administration (FDA) 510(k) clearance for its Prosigna breast cancer prognostic gene ...
-
IPAB Cancelled The Patent for GSK's Anti-Cancer Drug Tykerb
Aug 6, 2013The Intellectual Property Appellate Board (IPAB) in India has cancelled the patent for GlaxoSmithKline's (GSK) anti-cancer drug Tykerb in its salt form over failure in demonstrating significant improvement in the efficacy. Fresenius ...
Tags: Anti-Cancer Drug
-
CSii at Mcmaster University Has Announced Additional Funding
Dec 5, 2012The Centre for Surgical Invention and Innovation (CSii) at McMaster University has announced additional funding for the next phase of development of MacDonald, Dettwiler and Associates' (MDA) advanced technology solution for use in early ...
Tags: CSii, MDA, treatment of breast cancer
-
Ventana Medical Systems Has Received FDA Approval
Nov 30, 2012Ventana Medical Systems has received FDA approval for the application of its INFORM HER2 Dual ISH DNA Probe cocktail assay (HER2 Dual ISH) on the BenchMark ULTRA automated slide staining platform. The BenchMark XT instrument, the HER2 ...
Related Products
-
Zebrago Supply 99.8% Trilostane Powder for Treatment Breast Cancer
-
Oral Tablets Anti-Estrogen Raw Powder for Breast Cancer Treatment
-
CAS 129453-61-8 Factory Supply Anti-Cancer Fulve Strant Powder Treatment of Breast Cancer
-
Breast Cancer Treatment Pure Raws Powder Proge
-
High Quality Fulves Trant CAS 129453-61-8 Treatment of Breast Cancer
-
High Quality Eribulin CAS 253128-41-5 Treatment of Breast Cancer
